Rest-Of-Europe Gastrointestinal Stent Market Size, Share,Trends, Growth Analysis Report, 2031

Name: Rest-Of-Europe Gastrointestinal Stent Market Size, Share,Trends, Growth Analysis Report, 2031
Creator: MarketsandMarkets

Overview Request Sample Pages Request Customization Download PDF

You are viewing: Rest Of Europe Gastrointestinal Stent Market analysis

Part of: Gastrointestinal Stent Market (Global)

The Rest Of Europe Gastrointestinal Stent Market was valued at $14.98 Million in 2026 and projected to reach to $18.38 Million by 2031, representing a compound annual growth rate of 4.2%. Rest Of Europe's gastrointestinal stent market is positioned for steady growth through 2031, driven by rising gastrointestinal disorder prevalence and healthcare system modernization.

Rest Of Europe Gastrointestinal Stent Market (2026-2031) : Size and Share

CAGR of

USD Million

Rest Of Europe Gastrointestinal Stent Market Trends and Insights

The region is projected to experience steady growth, reaching $18.38 million by 2031, driven by increasing prevalence of gastrointestinal disorders and rising adoption of minimally invasive procedures across Rest Of Europe.
This 4.2% compound annual growth rate reflects moderate but consistent expansion in Rest Of Europe's healthcare infrastructure and patient access to advanced stent technologies. The gastrointestinal stent market in Rest Of Europe is characterized by growing demand for both esophageal and biliary stent applications, supported by an aging population and improved diagnostic capabilities.
Rest Of Europe's healthcare systems are increasingly investing in endoscopic interventions, which has bolstered market penetration between 2026 and 2031.
Key drivers include regulatory approvals for innovative stent designs, expanding reimbursement coverage, and heightened clinical awareness among gastroenterologists practicing across Rest Of Europe. Rest Of Europe's competitive landscape features both established medical device manufacturers and emerging regional players, creating a dynamic market environment.
The forecast period through 2031 suggests Rest Of Europe will maintain its growth trajectory as healthcare providers continue to prioritize patient outcomes and cost-effective treatment solutions in gastrointestinal care..

Key Market Statistics

CAGR (2026-2031) 4.2% CAGR
Market Size, 2026 ~USD 14.98 Million
Forecast, 2031 ~USD 18.38 Million
Country Rest Of Europe

Rest Of Europe Gastrointestinal Stent Market Overview

Market Size Growth :

Rest Of Europe's gastrointestinal stent market is valued at $14.98 million in 2026 and is projected to reach $18.38 million by 2031, representing consistent expansion in this specialized medical device segment.

Steady CAGR Performance :

The region demonstrates a 4.2% compound annual growth rate from 2026 to 2031, slightly below the global average of 5.7%, indicating moderate but stable market development across Rest Of Europe.

Minimally Invasive Adoption :

Rising adoption of minimally invasive procedures across Rest Of Europe is driving demand for gastrointestinal stents, as healthcare providers and patients increasingly prefer less invasive treatment options.

Disease Prevalence Drivers :

Increasing prevalence of gastrointestinal disorders throughout Rest Of Europe is a primary growth catalyst, supported by aging populations and changing lifestyle factors across the region.

Rest Of Europe Gastrointestinal Stent Market Dynamics

The region's 4.2% CAGR reflects consistent demand for advanced stent technologies and minimally invasive interventions.
Healthcare providers across Rest Of Europe are increasingly adopting these devices to improve patient outcomes and reduce hospital stays.
Market expansion is supported by improving reimbursement policies and growing awareness of gastrointestinal conditions among both healthcare professionals and patients in the region..

Related Ecosystem

Medical Devices

Top Technologies

Polymerase Chain Reaction (PCR)
Magnetic Resonance Imaging (MRI)
Disposable Autoinjectors
Pulse Oximeters
Blood Pressure Monitors

Top Companies

Medtronic plc
Abbott Laboratories
Stryker Corporation
Becton, Dickinson and Company
CONMED Corporation

Key Takeaways

Rest Of Europe's gastrointestinal stent market is valued at $14.98 million in 2026 and is expected to grow to $18.38 million by 2031 at a 4.2% CAGR.
Rest Of Europe demonstrates steady adoption of minimally invasive endoscopic procedures, supporting consistent market expansion through the forecast period.
Regulatory approvals and expanding reimbursement policies in Rest Of Europe are key catalysts driving gastrointestinal stent market growth.
Rest Of Europe's aging population and rising prevalence of gastrointestinal disorders create sustained demand for advanced stent technologies.

Gastrointestinal Stent Market Report Scope

Report Metric	Details
Base Year	2026
Fastest Growing Segment	BIODEGRADABLE STENTS (Type)
Forecast Period	2026�2031
Growth Rate	CAGR of 5.7% from 2026 to 2031
Largest Segment	HOSPITALS & CLINICS (End User)
Market Size Base Year (Billions)	~USD 0.62 (2026)
Revenue Forecast (Billions)	~USD 0.82 (2031)
Segments Covered	Product, Type, Mechanism, Coverage, Application, End User

Rest Of Europe Gastrointestinal Stent Market Report Segmentation

6 segment dimensions are covered across the global market.

By Product

Biliary Stents
Biodegradable Stents
Colonic Stents
Duodenal Stents
Esophageal Stents
Metal Stents
Pancreatic Stents
Plastic Stents

By Type

Biliary Stents
Biodegradable Stents
Colonic Stents
Colorectal Cancer
Duodenal Stents
Esophageal Cancer
Esophageal Stents
Magnesium-Based Stents
Metal Stents
Nitinol Stents
Other Biodegradable Stents
Other Metal Stents
Pancreatic Cancer
Pancreatic Stents
Plastic Stents
Polymer-Based Stents
Stainless Steel Stents
Stomach Cancer

By Mechanism

Balloon-Expandable Metal Stents (Bems)
Self-Expanding Metal Stents (Sems)

By Coverage

Fully Covered Stents
Partially Covered Stents
Uncovered Stents

By Application

Benign Strictures & Leaks
Biliary Disease
Biliary Diseases
Gastrointestinal Cancer
Other Applications

By End User

Ambulatory Surgical Centers
Hospitals & Clinics
Specialty Endoscopy Centers/Gi Clinics

Target Audience

Medical Device Manufacturers : Manufacturers need Rest Of Europe-specific market data to develop regional product strategies, identify growth opportunities, and allocate R&D resources effectively for this emerging market segment.
Healthcare Investors : Investors require detailed Rest Of Europe market analysis to evaluate investment opportunities in gastrointestinal stent companies and assess regional market potential and profitability.
Hospital & Clinical Networks : Healthcare providers need market insights to understand procurement trends, budget planning, and technology adoption patterns specific to Rest Of Europe's gastrointestinal stent market.
Market Consultants : Consultants advising healthcare and medical device clients require Rest Of Europe-specific data to provide accurate market assessments, competitive analysis, and strategic recommendations.
Regulatory & Policy Bodies : Healthcare regulators and policy makers in Rest Of Europe need market data to inform reimbursement policies, regulatory frameworks, and healthcare resource allocation decisions.

Key Companies in the Rest Of Europe Gastrointestinal Stent Market

Company	HQ	Ownership	Strongest segments
ATS AUTOMATION TOOLING SYSTEMS INC	Canada	Public Company	Custom automated manufacturing and assembly systems,Pre- and post-automation services and lifecycle support,Contract manufacturing and integration services,
BOSTON SCIENTIFIC CORPORATION	United States	Public Company	Cardiovascular (coronary, structural heart, CRM, peripheral),MedSurg � Endoscopy (GI, pancreaticobiliary, infection prevention),MedSurg � Urology and Pelvic Health,
OLYMPUS CORPORATION	Japan	Public Company	Gastrointestinal Solutions (endoscopes, devices, services),Surgical Endoscopes & Integrated OR Solutions,Advanced Energy Devices,
M.I. TECH	Malaysia	Public Company	Die sorting and smart binning equipment,Test handling and vision inspection equipment,Laser bonding and precision bonding equipment,
MICRO-TECH (NANJING) CO., LTD.	China	Public Company	Digestive endoscopy � ESD and ERCP (therapeutic devices and accessories),Stents and dilation/biopsy systems (biliary, intestinal, esophageal),Hemostasis, EUS, and diagnostic accessories,
MERIT MEDICAL SYSTEMS	United States	Public Company	Cardiovascular access and intervention (micropuncture, sheaths, guidewires, angiography, hemostasis),Peripheral intervention and embolotherapy (angiography, drainage, delivery, embolic solutions),Oncology and spine (soft tissue biopsy, vertebral augmentation, RF ablation, bone biopsy),
MEDTRONIC	Ireland	Public Company	Cardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio,
STERIS	Ireland	Public Company	Healthcare sterilization, decontamination, and OR infrastructure,Applied Sterilization Technologies (outsourced sterilization services),Life sciences contamination control and processing,
BD	United States	Public Company	Medical Essentials (IV access, syringes, needles, sharps, vascular care),Connected Care (infusion systems, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems),
Q3 MEDICAL GROUP	Ireland	Private Company	Specialty procedures and interventions,Outpatient and ambulatory services,Diagnostics and imaging,
BVM	Tunisia	Public Company	Fire, miscellaneous accidents, and engineering,Marine, energy, and aviation (including pools),Agricultural and emerging risks,

ATS AUTOMATION TOOLING SYSTEMS INC

ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 that employs 7,000 people. The company specializes in automation and tooling systems.

BOSTON SCIENTIFIC CORPORATION

Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. The company operates in the medical device and healthcare sectors.

OLYMPUS CORPORATION

Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates across imaging, medical, and industrial technology sectors.

M.I. TECH

M.I. Tech is a Malaysian public company founded in 2007 with 594 employees. The company operates in the technology sector.

MICRO-TECH (NANJING) CO., LTD.

Micro-Tech (Nanjing) Co., Ltd. is a Chinese public company founded in 2000 with 2,433 employees. The company operates in the medical device industry.

MERIT MEDICAL SYSTEMS

Merit Medical Systems is a United States-based public company founded in 1987 with 7,500 employees. The company manufactures and distributes medical devices and supplies.

MEDTRONIC

Medtronic is an Ireland-based public company founded in 1949 with 95,000 employees. The company is a global leader in medical technology, services, and solutions.

STERIS

STERIS is an Ireland-based public company founded in 1985. The company provides sterilization and contamination control solutions for healthcare and industrial markets.

BD

BD is a United States-based public company founded in 1897 with 72,000 employees. The company is a global medical technology company specializing in medical devices, diagnostics, and biosciences.

Q3 MEDICAL GROUP

Q3 Medical Group is an Ireland-based private company founded in 2013. The company operates in the medical device or healthcare sector.

BVM

BVM is a Tunisia-based public company founded in 1981 with 99 employees. The company operates in the medical or industrial sector.

Reasons to Buy this Report

Regional Market Sizing : Obtain precise market valuation data specific to Rest Of Europe, including 2026 baseline ($14.98M) and 2031 projections ($18.38M), enabling accurate regional business planning and investment decisions.
Growth Trajectory Analysis : Understand the 4.2% CAGR specific to Rest Of Europe and how it compares to global trends (5.7%), helping identify regional opportunities and competitive positioning strategies.
Market Driver Insights : Access detailed analysis of key growth drivers in Rest Of Europe including gastrointestinal disorder prevalence, minimally invasive procedure adoption rates, and healthcare infrastructure developments.
Competitive Landscape : Gain intelligence on Rest Of Europe-specific market dynamics, regulatory environment, and competitive positioning to inform product development and market entry strategies for the region.
Strategic Planning Support : Leverage comprehensive Rest Of Europe market data to support business case development, resource allocation, and long-term strategic planning for gastrointestinal stent market expansion.

Frequently asked questions

What is the current market size of gastrointestinal stents in Rest Of Europe?

Rest Of Europe's gastrointestinal stent market was valued at $14.98 million in 2026 and is projected to reach $18.38 million by 2031.

What is the expected growth rate for the gastrointestinal stent market in Rest Of Europe?

Rest Of Europe's gastrointestinal stent market is expected to grow at a compound annual growth rate (CAGR) of 4.2% from 2026 to 2031.

What factors are driving growth in Rest Of Europe's gastrointestinal stent market?

Key growth drivers in Rest Of Europe include an aging population, rising prevalence of gastrointestinal disorders, increased adoption of minimally invasive procedures, regulatory approvals for innovative stent designs, and expanding reimbursement coverage.

Which stent types are most commonly used in Rest Of Europe?

Rest Of Europe's market includes both esophageal and biliary stent applications, with demand driven by diverse clinical indications and healthcare provider preferences across the region.

Who are the main competitors in Rest Of Europe's gastrointestinal stent market?

Rest Of Europe's competitive landscape includes established multinational medical device manufacturers alongside emerging regional players, creating a dynamic and diverse market environment.

RESEARCH METHODOLOGY

This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

Secondary Research

This research study utilized a variety of comprehensive secondary sources, including directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the gastrointestinal stent market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

Primary Research

In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the gastrointestinal stent market. Primary sources from the demand side include gastroenterologists, interventional endoscopists, and surgeons from hospitals and ambulatory surgical centers, as well as directors of endoscopy units and gastrointestinal clinics.

A breakdown of the primary respondents is provided below:

Gastrointestinal Stent Market
Size, and Share

Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

Note 2: Other designations include sales, marketing, and product managers.

Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the gastrointestinal stent market was determined through data triangulation using three approaches, as outlined below. After each approach, the weighted average of the three approaches was calculated based on the level of assumptions used in each.

Gastrointestinal Stent Market : Top-Down and Bottom-Up Approach

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed where applicable to complete the overall market engineering process and derive the exact statistics for all segments and subsegments.

Market Definition

The gastrointestinal stent market comprises medical devices designed for the minimally invasive management of obstructions, strictures, leaks, and fistulas within the gastrointestinal tract, including the esophagus, stomach, intestines, and biliary system. These stents, primarily self-expanding metal, plastic, and biodegradable variants, are deployed endoscopically or fluoroscopically to restore luminal patency, enable fluid drainage, and support tissue healing in both malignant and benign conditions. The market includes products, delivery systems, and associated technologies used across hospitals, ambulatory surgical centers, and specialty clinics, with applications spanning oncology, post-surgical complications, and chronic gastrointestinal disorders, driven by the growing preference for minimally invasive treatment approaches and improved patient outcomes.

Key Stakeholders

GI stent manufacturers (metal, plastic, biodegradable stents)
Endoscopy device & delivery system manufacturers
Raw material & component suppliers (metals, polymers, coatings)
Hospitals & ambulatory surgical centers (public & private)
Gastroenterology clinics & endoscopy centers
Gastroenterologists, interventional endoscopists & GI surgeons
Contract manufacturers & OEM partners
Distributors & regional channel partners
Academic & clinical research institutions
Regulatory authorities & healthcare agencies
Market research & consulting firms
Investors & private equity firms

Report Objectives

To define, describe, segment, and forecast the gastrointestinal stent market by product, type, application, end user, and region
To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall gastrointestinal stent market
To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
To forecast the size of the gastrointestinal stent market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
To profile the key players in the gastrointestinal stent market and comprehensively analyze their core competencies and market shares
To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

Customization Options:

With the market data provided, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

Geographic Analysis

Further breakdown of the Rest of Europe gastrointestinal stent market into Austria, Finland, Switzerland, and other countries
Further breakdown of the Rest of Latin America gastrointestinal stent market into Colombia, Chile, and other countries

Competitive Landscape Assessment

Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the gastrointestinal stent market
Competitive leadership mapping for established players in the US

Get the Full Gastrointestinal Stent Market Report

Full forecast, segment splits, and company analysis for all Gastrointestinal Stent Market.

Download Sample Pages Buy Report

REPORT COVERAGE

＋

Report Description
Market Overview
Market Dynamics
Related Ecosystem
Key Takeaways
Market Scope
Report Segmentation
Target Audience
Key Companies

Market Size in	USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered	Value (USD MN)